New diagnostic techniques and treatments for early breast cancer

Seminars in oncology nursing

Volumn 16, Issue 3, 2000, Pages 185-196

  Mautner, Beatrice D ^a   Schmidt, Kristi V ^b   Brennan, Meghan B ^c  

^a St John Providence Health System   (United States)

^b Providence Cancer Center   (United States)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

BREAST TUMOR; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MAMMOGRAPHY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY NURSING; PATHOLOGY; PATIENT EDUCATION; REVIEW;

ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING; ONCOLOGIC NURSING; PATIENT EDUCATION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034243714     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2000.8112     Document Type: Article

References (60)

1. Soran A Vogel VG Optimal management of primary breast cancer Breast J 5 1999 81 93
2. Fremgen AM Bland KI McGinnis LS Clinical highlights from the National Cancer Data Base, 1999 CA Cancer J Clin 49 1999 145 158
3. American Joint Commission on Cancer Breast Fleming ID Cooper JS Henson DE Hutter RVP Kennedy BJ Murphy GP O'Sullivan B Sobin LH Yarbro JW Cancer Staging Handbook 1988 Lippincott-Raven Philadelphia, PA 159 169
4. Thurfjell EL Lerneval KA Taube AAS Benefit of independent double reading in a population-based mammography screening program Radiology 191 1994 241 244
5. Orel SG High-resolution MR imaging for the detection, diagnosis, and staging of breast cancer Radiographics 18 1998 903 912
6. Dershaw DD Fleischman RC Liberman L Use of digital mammography in needle localization procedures AJR Am J Roentgenol 161 1993 559 562
7. Trevathan-Ramirez D Innovations in breast disease diagnosis Radiol Technol 2 1998 197 203
8. Hall FM Sonography of the breast: Controversies and opinions AJR Am J Roentgenol 169 1997 1635 1636
9. Stavros AT Thickman D Rapp CL Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions Radiology 196 1995 123 134
10. Kolb TM Lichy J Newhouse JH Occult cancer in women with dense breasts: Detection with screening US-diagnostic yield and tumor characteristics Radiology 207 1998 191 199
11. Raza S Baum JK Solid breast lesions: Evaluation with power doppler US Radiology 203 1997 164 168
12. Weind KL Maier CF Rutt BK Invasive carcinomas and fibroadenomas of the breast: Comparison of microvessel distributions-Implications for imaging modalities Radiology 208 1998 477 483
13. Boetes C Mus RDM Holland R Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent Radiology 197 1995 743 747
14. Esserman L Hylton N Yassa L Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging J Clin Oncol 17 1999 110 119
15. Wahl RL Cody RL Hutchins GD Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 179 1991 765 770
16. 142P Jacobs M Mantil C Peterson R FDG PET in breast cancer (abstr 571) Proc Soc Nucl Med 35 1994
17. 142P Wahl RL Zasadny KR Cody R FDG accumulation in normal breasts declines with aging (abstr 572) Proc Soc Nucl Med 35 1994
18. December 7 Henderson C Ultrasound design expands mammotome applications Cancer Weekly Plus 1996
19. October 7 Henderson C Women with breast implants can receive non-surgical biopsy Cancer Weekly Plus 1996
20. Matthews BD Williams GB Initial experience with the advanced breast biopsy instrumentation system Am J Surg 177 1999 97 101
21. Pettine S Place R Babu S Stereotactic breast biopsy is accurate, minimally invasive, and cost effective Am J Surg 171 1996 474 476
22. Gentry CL Henry CA Stereotactic percutaneous breast biopsy: A comparative analysis between the surgeon and radiologist Breast J 5 1999 101 104
23. Wisecarver J HER-2/neu testing comes to age Am J Clin Pathol 111 1999 299 301
24. Neiderhuber J Multimodality treatment of stage I and II breast cancer Roses D Breast Cancer 1999 Churchill Livingstone New York, NY 309 342
25. Pegram M Pauletti G Slamon D HER-2/neu as a predictive marker of response to breast cancer therapy Breast Cancer Res Treat 52 1998 65 77
26. (CD-ROM) Fearson E Oncogenes and tumor suppressor genes Abeloff M Armitage J Lichter A Clinical Oncology 1995 Churchill Livingstone New York, NY
27. Hortobagyi G Treatment of breast cancer N Engl J Med 339 1998 974 982
28. National Institute of Health Consensus Conference Treatment of early breast cancer JAMA 265 1991 391 395
29. Morton D Wen DR Wong J Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392 399
30. Giuliano AE Kirgan DM Guenther JM Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 1994 390 401
31. Krag DN Weaver DL Alex JC Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe Surg Oncol 2 1993 235 340
32. Giuliano AE Dale PS Turner RR Improved axillary staging of breast cancer with sentinel lymphadenectomy Ann Surg 222 1995 394 401
33. Albertini JJ Lyman GH Cox C Lymphatic mapping and sentinel node biopsy in the patient with breast cancer JAMA 276 1996 1818 1822
34. Pijpers R Miejer S Hoekstra OS Impact of lymphoscintigraphy on sentinel node identification with Technetium-99-Colloidal albumin in breast cancer J Nucl Med 38 1997 366 368
35. Veronesi U Paganelli G Galimberti V Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Lancet 349 1997 1864 1867
36. Guenther JM Krishnamoorthy M Tan LR Sentinel lymphadenectomy for breast cancer in a community managed care setting Cancer J Sci Am 3 1997 336 340
37. Dale PS Williams JT Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma Am Surg 64 1998 28 32
38. Borgstein PJ Pijpers R Comans EF Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection J Am Coll Surg 186 1998 275 283
39. Barnwell JM Arredondo MA Kollmorgen D Sentinel node biopsy in breast cancer Ann Surg Oncol 5 1998 126 130
40. O'Hea BJ Hill AD El-Shirbiny AM Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center J Am Coll Surg 186 1998 423 427
41. Miner TJ Shriver CD Jaques DP Ultrasonographically guided injection improves localization of the radiolabelled sentinel lymph node in breast cancer Ann Surg Oncol 5 1998 315 321
42. Cox CE Pendas S Cox JM Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer Ann Surg 227 1998 645 653
43. Koller M Barsuk D Zippel S Sentinel lymph node involvement-A predictor for axillary node status with breast cancer-Has the time come? Eur J Surg Oncol 24 1998 166 168
44. Crossin JA Johnson AC Sterwart PB Gammaprobe guided resection of the sentinel lymph node in breast cancer Am Surg 64 1998 666 669
45. Krag DN Weaver DI Ashikaga T The sentinel node in breast cancer: A multicenter validation study N Engl J Med 339 1998 941 946
46. Turner RR Ollila DW Krasne DL Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma Ann Surg 226 1997 271 278
47. Fisher E Swamidoss S Lee C Detection and significance of occult axillary node metastases in patients with invasive breast cancer Cancer 42 1978 2025 2031
48. Harris JR Morrow M Local management of invasive breast cancer Harris JR Lippman ME Morrow M Hellman S Diseases of the Breast 1996 Lippincott-Raven Philadelphia, PA 487 547
49. National Institutes of Health Consensus Development Panel Consensus Statement Treatment of early-stage breast cancer J Natl Cancer Inst Monogr 11 1992 11 15
50. Fowble B Results of prospective randomized trials evaluating postmastectomy radiation for axillary node-positive patients receiving adjuvant systemic therapy 1999 American Society of Clinical Oncology Educational Book Alexandria, VA 623 628
51. Recht A Local-regional failure rates after mastectomy among patients treated with chemotherapy and tamoxifen 1999 American Society of Clinical Oncology Educational Book Alexandria, VA 635 639
52. Recht A Come S Gelman R Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage node-positive breast cancer: Sequencing, timing, and outcome J Clin Oncol 9 1991 1662 1667
53. Recht A Come SA The optimal sequence of administration of radiation therapy and chemotherapy in patients with early and locally advanced breast cancer Semin Breast Dis 2 1999 135 144
54. Buchholz TA Hunt KK Amosson CM Sequencing of chemotherapy and radiation in lymph node-negative breast cancer Cancer J Sci Am 5 1999 159 164
55. (abstr 271) Wolmark N Dignam J Margolese R The role of radiotherapy and tamoxifen in the management of node-negative invasive breast cancer—1. OCM treated with lumpectomy: Preliminary results of NSABP B-21 Proc Am Soc Clin Oncol 19 2000 70a
56. Sledge G Miller K Metastatic breast cancer: The role of chemotherapy Semin Oncol 26 suppl 2 1999 6 10
57. Oratz R Treatment of metastatic breast cancer: Chemotherapy Roses D Breast Cancer 1999 Churchill Livingstone New York, NY 515 521
58. D'Andrea G Seidman A Docetaxel and paclitaxel in breast cancer therapy: Present status and future prospects Semin Oncol 24 suppl 13 1997 S13
59. (abstr 390A) Henderson IC Berry D Demetri G Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (pts) with node-positive primary breast cancer (BC) Proc Am Soc Clin Oncol 17 1998 101a
60. Piccart-Gebhart M What can be expected from the next generation of adjuvant breast cancer treatment? Semin Oncol 26 suppl 3 1999 22 25